Finance

Beta
Lists
4272:TYO
Nippon Kayaku Co Ltd
Â¥2,132.50
+0.12%
(+2.50) 1D
May 29, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4272...
Open
Â¥2,150
High
Â¥2,159
Low
Â¥2,116
Mkt. cap
317.10B
Avg. vol.
560.66K
Volume
904.20K
Dividend
3.09%
Quarterly dividend
Â¥17
Ex-dividend date
Mar 30, 2026
P/E ratio
13.23
52-wk high
Â¥2,192
52-wk low
Â¥1,277
EPS
Â¥161
Shares outstanding
173.15M
No. of employees
6K
Open
Â¥2,150
High
Â¥2,159
Low
Â¥2,116
Mkt. cap
317.10B
Avg. vol.
560.66K
Volume
904.20K
Dividend
3.09%
Quarterly dividend
Â¥17
Ex-dividend date
Mar 30, 2026
P/E ratio
13.23
52-wk high
Â¥2,192
52-wk low
Â¥1,277
EPS
Â¥161
Shares outstanding
173.15M
No. of employees
6K
News stories
From sources across the web
Profile
Nippon Kayaku is a Japanese chemical and pharmaceutical company that was founded in 1916 as the first industrial explosives manufacturer in Japan under the company name Nippon Kayaku Seizo Co., Ltd.. Its main business areas are functional chemicals, pharmaceuticals, safety systems and agrochemicals. The company operates 8 plants and 4 laboratories in Japan. It also has subsidiaries in different countries around the world. It is listed on the Nikkei 225. Wikipedia
About Nippon Kayaku Co Ltd
CEO-
Employees5.98K
FoundedJun 5, 1916
Headquarters-
SectorSpeciality chemicals
Websitenipponkayaku.co.jp
Last report
May 12, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
67.25B / 64.90B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
54.76B
58.82B
61.02B
67.25B
Cost of goods sold
38.19B
41.52B
42.62B
46.63B
Cost of revenue
38.19B
41.52B
42.62B
46.63B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.20B
11.04B
12.70B
14.49B
Operating expense
12.20B
11.04B
12.70B
14.49B
Total operating expenses
50.39B
52.57B
55.32B
61.12B
Operating income
4.37B
6.25B
5.70B
6.13B
Other non operating income
89.00M
117.00M
143.00M
15.00M
EBT including unusual items
6.01B
10.56B
7.85B
9.17B
EBT excluding unusual items
4.07B
6.78B
7.86B
6.78B
Income tax expense
1.70B
3.14B
2.19B
1.85B
Effective tax rate
28.21%
29.77%
-
20.13%
Other operating expenses
-
-
-
-
Net income
4.29B
7.40B
5.63B
7.32B
Net profit margin
7.84%
12.58%
-
10.88%
Earnings per share
-
-
-
-
Interest and investment income
599.00M
284.00M
407.00M
208.00M
Interest expense
-142.00M
-60.00M
-225.00M
-45.00M
Net interest expenses
457.00M
224.00M
182.00M
163.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.89B
10.02B
9.22B
10.07B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer